Meena Stoke

Meena Stoke

Company: Stoke Therapeutics

Job title: Vice President of Bioanalytical, DMPK & Biomarker Development


Challenges in Designing Pre-Clinical Toxicity Studies for Oligonucleotides & Their Clinical Relevance 11:30 am

Lessons learned from approved oligonucleotide therapeutics (ONTs) Lack of specific regulatory guidance for development of ONTs Considerations for development of ONTsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.